A TEST FOR MACULAR DEGENERATION
– The history of the Macular Mapping Test 2.0
The developers’ long-term experience with patients suffering from AMD or other diseases affecting the central visual field created the demand for a simple and inexpensive visual field test beyond conventional perimetry.
The test should be brief, easy to perform for predominantly elderly people and provide results that can be understood without special knowledge. In addition to the original goal to examine residual vision, the test should also be sensitive enough to detect symptoms of AMD early and be useful as a screening tool.
The Macular Mapping Test (MMT) was originally developed by Manfred MacKeben, Ph.D. and August Colenbrander, M.D. at the Smith-Kettlewell Eye Research Institute in San Francisco, CA, USA.
A new concept for the user interface was developed in 2015 under the direction of Prof. Dr. Werner Eisenbarth, Munich University of Applied Sciences, based on an ongoing cooperation with Dr. MacKeben. The aim was to adapt the Macular Mapping Test to the day-to-day requirements of optometry and ophthalmology. The result is the new Macular Mapping Test 2.0 (MMT 2.0).
Prof. Dr. Werner Eisenbarth
PROF. DR. WERNER EISENBARTH
Member of the German Ophthalmological Society (DOG) and the Association of German Contact Lens Specialists and Optometrists (VDCO).
Curriculum Vitae –
Studies at the Technical University and Ludwig-Maximilian-University Munich, since 2002 co-operation with the Smith-Kettlewell Eye Research Institute in San Francisco and since 2008 with the Department of Ophthalmology at the Klinikum rechts der Isar of the TU Munich.
Since 2011 professor for physiology of vision at the University of Munich. 2016 appointment as Clinical Director of the “Opening Eyes” program at Special Olympics, an IOC-recognized sports organization for people with mental and multiple disabilities. 2015 Foundation of the Center for Applied Vision Research at the University of Munich (www.zefas.de).
Recipient of the Constance W. Atwell Award 2004, for excellence in low vision research (Research Prize of the Low Vision Research Group of the Association for Research in Vision and Ophthalmology, ARVO, USA)
Publications on the topic
Eisenbarth W, Richert J, MacKeben M. (2016) Testing macular letter recognition – reliability and influence of refraction errors. Clin Exp Optom. 99(4):322-7.
Eisenbarth W., Feucht N., Enders C., Maier M., Lohmann C.P., MacKeben M. (2015) Parafoveal contributions to retinal function during ranibizumab therapy for age-related macular degeneration. Can J Ophthalmol. 50(1):37-43.
Eisenbarth, W., MacKeben, M. (2008) „Macular Mapping“ – AMD Screening für Augenoptiker, DOZ, 7:32-36.
MacKeben M. (2008) Topographic mapping of residual vision by computer. J. Visual Impairment & Blindness (Special Issue on AMD), October, Vol. 102, No.10, 649-6.
MacKeben,M. & Colenbrander, A. (2000) Topographic measurements of low contrast letter recognition as a tool for diagnosis and vision rehabilitation. Vision Rehabilitation (C.Stuen et al., eds), Swets & Zeitlinger, Lisse, pp. 158-160.
MacKeben M., Colenbrander, A. & Gofen, A. (1999) Use your PC to quickly map remaining vision after foveal vision loss. Perimetry Update 1998/1999 (M.Wall & J.M.Wild, eds.), pp.307-316, Kugler Publications, The Hague
MacKeben, M., Colenbrander, A.. and Schainholz,D. (1994) Comparison of Three Ways to Assess Residual Vision after Macular Vision Loss. In: “Low Vision – Research and New Developments in Rehabilitation”, Kooijman AC et al. (Eds.), IOS Press, Amsterdam, pp. 51-58.
MacKeben, M. and Colenbrander, A. (1994) Mapping the topography of residual vision after macular vision loss. In: “Low Vision – Research and New Developments in Rehabilitation”, Kooijman AC et al. (Eds.), IOS Press, Amsterdam, pp. 59-67.